Publications November 15, 2018 – Legal Alerts FDA Proposes Changes to Clinical Trial Informed Consent Rules Bryan P. Murray October 23, 2018 – Legal Alerts Ohio Medical Professionals Now Must Report Suspected Elder Abuse Thomas W. Hess, Jennifer Orr Mitchell and Eric J. Plinke October 1, 2018 – Legal Alerts Three Boston Hospitals Pay Close to $1 Million in HIPAA Settlements for Disclosing Personal Health Information to Film Crews Matthew S. Arend, Jennifer Orr Mitchell and Eric J. Plinke September 18, 2018 – Legal Alerts CMS Proposes to Reduce Medicare CoPs and CfCs Burdens Bryan P. Murray September 18, 2018 – Legal Alerts Federal Judge Vacates Medicare Advantage Overpayment Rule Jared M. Bruce September 13, 2018 – Legal Alerts Ohio Physician Assistant Process Streamlined and Burdens Reduced for Employers and Physicians Eric J. Plinke and Daniel S. Zinsmaster August 28, 2018 – Legal Alerts OIG Considering Changes to Anti-kickback Statute and CMP Law Bryan P. Murray August 23, 2018 – Legal Alerts Attorney General Sessions Announces First Ever Controlled Substances Act Civil Injunctions Jared M. Bruce and Jennifer Orr Mitchell July 27, 2018 – Legal Alerts CMS Extends Medicare Part B 340B Drug Reimbursement Policies Jennifer Orr Mitchell and Eric J. Plinke February 20, 2018 – Legal Alerts Medical Board Seeks Non-Disciplinary Program for Providers Suffering From Mental and Physical Conditions Eric J. Plinke, Daniel S. Zinsmaster and Courtney M. White January 26, 2018 – Legal Alerts State Medical Board of Ohio Proposes Changes to Medical Laser Rules Eric J. Plinke October 12, 2017 – Legal Alerts State of Ohio Board of Pharmacy Extends Deadline for Office-Based Opioid Treatment Providers to Obtain Terminal Distributor License Eric J. Plinke and Daniel S. Zinsmaster August 1, 2017 – Legal Alerts Are Ohio Prescribers and Pharmacies Prepared for the New Requirement to Include ICD-10 Diagnosis Codes on All Controlled Substance Prescriptions? Eric J. Plinke and Daniel S. Zinsmaster December 27, 2016 – Articles Unintended Consequences of Ohio's S.B. 319 Could Reduce Access to Addiction Treatment Eric J. Plinke and Daniel S. Zinsmaster December 2, 2016 – Articles Effective December 1, Pharmacies, Prescribers, and Wholesalers Must Report Gabapentin to OARRS Eric J. Plinke and Daniel S. Zinsmaster June 20, 2016 – Articles Deadline Extended for Sole Proprietors to Register with Board of Pharmacy as Terminal Distributors of Dangerous Drugs Eric J. Plinke and Daniel S. Zinsmaster April 29, 2016 – Articles New Board of Pharmacy Regulations Significantly Narrow the Sole Proprietor Exemption and Impose New Compounding Standards Eric J. Plinke and Daniel S. Zinsmaster April 4, 2016 – Articles Proposed Rule Seeks to Increase Access to Treatment for Opioid and Heroin Abuse Eric J. Plinke and Daniel S. Zinsmaster August 7, 2015 – Articles Ohio’s New OARRS Standards and Procedures Eric J. Plinke, Daniel S. Zinsmaster Page 2 of 2 Previous
November 15, 2018 – Legal Alerts FDA Proposes Changes to Clinical Trial Informed Consent Rules Bryan P. Murray
October 23, 2018 – Legal Alerts Ohio Medical Professionals Now Must Report Suspected Elder Abuse Thomas W. Hess, Jennifer Orr Mitchell and Eric J. Plinke
October 1, 2018 – Legal Alerts Three Boston Hospitals Pay Close to $1 Million in HIPAA Settlements for Disclosing Personal Health Information to Film Crews Matthew S. Arend, Jennifer Orr Mitchell and Eric J. Plinke
September 18, 2018 – Legal Alerts CMS Proposes to Reduce Medicare CoPs and CfCs Burdens Bryan P. Murray
September 18, 2018 – Legal Alerts Federal Judge Vacates Medicare Advantage Overpayment Rule Jared M. Bruce
September 13, 2018 – Legal Alerts Ohio Physician Assistant Process Streamlined and Burdens Reduced for Employers and Physicians Eric J. Plinke and Daniel S. Zinsmaster
August 28, 2018 – Legal Alerts OIG Considering Changes to Anti-kickback Statute and CMP Law Bryan P. Murray
August 23, 2018 – Legal Alerts Attorney General Sessions Announces First Ever Controlled Substances Act Civil Injunctions Jared M. Bruce and Jennifer Orr Mitchell
July 27, 2018 – Legal Alerts CMS Extends Medicare Part B 340B Drug Reimbursement Policies Jennifer Orr Mitchell and Eric J. Plinke
February 20, 2018 – Legal Alerts Medical Board Seeks Non-Disciplinary Program for Providers Suffering From Mental and Physical Conditions Eric J. Plinke, Daniel S. Zinsmaster and Courtney M. White
January 26, 2018 – Legal Alerts State Medical Board of Ohio Proposes Changes to Medical Laser Rules Eric J. Plinke
October 12, 2017 – Legal Alerts State of Ohio Board of Pharmacy Extends Deadline for Office-Based Opioid Treatment Providers to Obtain Terminal Distributor License Eric J. Plinke and Daniel S. Zinsmaster
August 1, 2017 – Legal Alerts Are Ohio Prescribers and Pharmacies Prepared for the New Requirement to Include ICD-10 Diagnosis Codes on All Controlled Substance Prescriptions? Eric J. Plinke and Daniel S. Zinsmaster
December 27, 2016 – Articles Unintended Consequences of Ohio's S.B. 319 Could Reduce Access to Addiction Treatment Eric J. Plinke and Daniel S. Zinsmaster
December 2, 2016 – Articles Effective December 1, Pharmacies, Prescribers, and Wholesalers Must Report Gabapentin to OARRS Eric J. Plinke and Daniel S. Zinsmaster
June 20, 2016 – Articles Deadline Extended for Sole Proprietors to Register with Board of Pharmacy as Terminal Distributors of Dangerous Drugs Eric J. Plinke and Daniel S. Zinsmaster
April 29, 2016 – Articles New Board of Pharmacy Regulations Significantly Narrow the Sole Proprietor Exemption and Impose New Compounding Standards Eric J. Plinke and Daniel S. Zinsmaster
April 4, 2016 – Articles Proposed Rule Seeks to Increase Access to Treatment for Opioid and Heroin Abuse Eric J. Plinke and Daniel S. Zinsmaster
August 7, 2015 – Articles Ohio’s New OARRS Standards and Procedures Eric J. Plinke, Daniel S. Zinsmaster